Bavarian Nordic A/S

OVERVALUEDBVNKF · OTC · Healthcare
BVNKF·OTC·Healthcare
OVERVALUED
Bavarian Nordic A/S
36.0%downside
MARKET PRICE
$30.73
FAIR PRICE
$19.66
MARGIN
$11.07
UNDERVALUEDFAIROVERVALUED
P/E RATIO
6.4x
DIV. YIELD
N/A
ROE
20.3%
MARKET CAP
$15B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

36.0%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$30.73

FAIR PRICE

$19.66

MARGIN

$11.07

UNDERVALUEDFAIROVERVALUED

P/E Ratio

6.4x

What is P/E? →

Div. Yield

N/A

ROE

20.3%

Strong

Market Cap

$15B

Large-cap

NOW AVAILABLE

Get notified when BVNKF's fair price changes

Push notifications when BVNKF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

8.7/ 10

Strong profitability and consistent growth trajectory, but volatile earnings pattern.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$15.73CONSERVATIVE ENTRY
$19.66FAIR PRICE
$30.73MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$15.73

Fair price × 0.80

DISTANCE

48.8%

Price to entry level

At the current price of $30.73, BVNKF trades 48.8% above the conservative entry level of $15.73. This entry level represents a 20% margin of safety below the calculated fair price of $19.66 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate BVNKF's fair price

Bavarian Nordic A/S's fair price of $19.66 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $30.73, BVNKF trades 36.0% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BVNKF's risk profile.

RELATIVE · 30%

Comparing BVNKF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for BVNKF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate BVNKF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for BVNKF.

Explore on Bulios

FAQ

What is the fair price of BVNKF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Bavarian Nordic A/S is $19.66. At the current market price of $30.73, BVNKF trades 36.0% above its calculated fair value.

Is BVNKF overvalued or undervalued?+

Bavarian Nordic A/S is currently overvalued based on our valuation model. The stock trades at $30.73, which is 36.0% above the fair price of $19.66. The P/E ratio of 6.4x is a key metric in the valuation.

What is the margin of safety for BVNKF?+

With a 20% margin of safety applied to the fair price of $19.66, the conservative entry level for BVNKF is $15.73. At the current market price of $30.73, the stock trades 48.8% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is BVNKF's fair price updated?+

We update fair price calculations for BVNKF daily after market close. The current fair price of $19.66 incorporates the latest market data and sector multiples.

What factors affect BVNKF's fair price calculation?+

BVNKF's fair price of $19.66 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 6.4x, ROE of 20.3%.

Is BVNKF a good buy right now?+

At $30.73, BVNKF trades 36.0% above our fair value estimate of $19.66. The stock is currently overvalued. ROE stands at 20.3% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does BVNKF pay dividends?+

BVNKF does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.